BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25432093)

  • 1. Visual field changes following implantation of the Argus II retinal prosthesis.
    Rizzo S; Belting C; Cinelli L; Allegrini L
    Graefes Arch Clin Exp Ophthalmol; 2015 Feb; 253(2):323-5. PubMed ID: 25432093
    [No Abstract]   [Full Text] [Related]  

  • 2. The Argus II Retinal Prosthesis: 12-month outcomes from a single-study center.
    Rizzo S; Belting C; Cinelli L; Allegrini L; Genovesi-Ebert F; Barca F; di Bartolo E
    Am J Ophthalmol; 2014 Jun; 157(6):1282-90. PubMed ID: 24560994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind.
    Ho AC; Humayun MS; Dorn JD; da Cruz L; Dagnelie G; Handa J; Barale PO; Sahel JA; Stanga PE; Hafezi F; Safran AB; Salzmann J; Santos A; Birch D; Spencer R; Cideciyan AV; de Juan E; Duncan JL; Eliott D; Fawzi A; Olmos de Koo LC; Brown GC; Haller JA; Regillo CD; Del Priore LV; Arditi A; Geruschat DR; Greenberg RJ;
    Ophthalmology; 2015 Aug; 122(8):1547-54. PubMed ID: 26162233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-Month Safety and Efficacy of the Intelligent Retinal Implant System II Device in Retinitis Pigmentosa.
    Muqit MMK; Velikay-Parel M; Weber M; Dupeyron G; Audemard D; Corcostegui B; Sahel J; Le Mer Y
    Ophthalmology; 2019 Apr; 126(4):637-639. PubMed ID: 30591229
    [No Abstract]   [Full Text] [Related]  

  • 5. [Postoperative imaging after ARGUS® II epiretinal prosthesis implantation in a patient with retinitis pigmentosa].
    Govare M; Korobelnik JF; Barale PO; Garrigues A; Fiorellini L; Gontier B; Delyfer MN
    J Fr Ophtalmol; 2016 Jan; 39(1):114-5. PubMed ID: 26654285
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of sham surgery on retinal function after subretinal transplantation of the artificial silicone retina.
    Del Priore LV
    Arch Ophthalmol; 2005 Aug; 123(8):1156; author reply 1156-7. PubMed ID: 16087860
    [No Abstract]   [Full Text] [Related]  

  • 7. The Toronto experience with the Argus II retinal prosthesis: new technology, new hope for patients.
    Devenyi RG; Manusow J; Patino BE; Mongy M; Markowitz M; Markowitz SN
    Can J Ophthalmol; 2018 Feb; 53(1):9-13. PubMed ID: 29426448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rehabilitation of lost functional vision with the Argus II retinal prosthesis.
    Markowitz M; Rankin M; Mongy M; Patino BE; Manusow J; Devenyi RG; Markowitz SN
    Can J Ophthalmol; 2018 Feb; 53(1):14-22. PubMed ID: 29426432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantation of the Argus II Retinal Prosthesis in an Eye With Short Axial Length.
    Montezuma SR; Tang PH; van Kuijk FJ; Drayna P; Koozekanani DD
    Ophthalmic Surg Lasers Imaging Retina; 2016 Apr; 47(4):369-71. PubMed ID: 27065379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive Visual Phenomena Following Implantation of the Argus II Retinal Prosthesis.
    Sadaka A; Iqbal C; Nazari H; Berry S; Wykoff CC; Humayun MS; Lee AG
    Ophthalmic Surg Lasers Imaging Retina; 2017 Dec; 48(12):1022-1025. PubMed ID: 29253307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved performance and safety from Argus II retinal prosthesis post-approval study in France.
    Delyfer MN; Gaucher D; Mohand-Saïd S; Barale PO; Rezaigua-Studer F; Ayello-Scheer S; Dollfus H; Dorn JD; Korobelnik JF; Sahel JA
    Acta Ophthalmol; 2021 Nov; 99(7):e1212-e1221. PubMed ID: 33354943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial.
    da Cruz L; Dorn JD; Humayun MS; Dagnelie G; Handa J; Barale PO; Sahel JA; Stanga PE; Hafezi F; Safran AB; Salzmann J; Santos A; Birch D; Spencer R; Cideciyan AV; de Juan E; Duncan JL; Eliott D; Fawzi A; Olmos de Koo LC; Ho AC; Brown G; Haller J; Regillo C; Del Priore LV; Arditi A; Greenberg RJ;
    Ophthalmology; 2016 Oct; 123(10):2248-54. PubMed ID: 27453256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Argus II retinal prosthesis system: An update.
    Rachitskaya AV; Yuan A
    Ophthalmic Genet; 2016 Sep; 37(3):260-6. PubMed ID: 26855177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Argus II epiretinal prosthesis system allows letter and word reading and long-term function in patients with profound vision loss.
    da Cruz L; Coley BF; Dorn J; Merlini F; Filley E; Christopher P; Chen FK; Wuyyuru V; Sahel J; Stanga P; Humayun M; Greenberg RJ; Dagnelie G;
    Br J Ophthalmol; 2013 May; 97(5):632-6. PubMed ID: 23426738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the electrode array-retina gap distance on visual function in patients with the Argus II retinal prosthesis.
    Naidu A; Ghani N; Yazdanie MS; Chaudhary K
    BMC Ophthalmol; 2020 Sep; 20(1):366. PubMed ID: 32943044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal Anatomy and Electrode Array Position in Retinitis Pigmentosa Patients After Argus II Implantation: An International Study.
    Gregori NZ; Callaway NF; Hoeppner C; Yuan A; Rachitskaya A; Feuer W; Ameri H; Arevalo JF; Augustin AJ; Birch DG; Dagnelie G; Grisanti S; Davis JL; Hahn P; Handa JT; Ho AC; Huang SS; Humayun MS; Iezzi R; Jayasundera KT; Kokame GT; Lam BL; Lim JI; Mandava N; Montezuma SR; Olmos de Koo L; Szurman P; Vajzovic L; Wiedemann P; Weiland J; Yan J; Zacks DN
    Am J Ophthalmol; 2018 Sep; 193():87-99. PubMed ID: 29940167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between visual disability and visual scores in patients with retinitis pigmentosa.
    Sumi I; Matsumoto S; Okajima O; Shirato S
    Jpn J Ophthalmol; 2000; 44(1):82-7. PubMed ID: 10698030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI brain scans in two patients with the argus II retinal prosthesis.
    Luo YH; Davagnanam I; dacCuz L
    Ophthalmology; 2013 Aug; 120(8):1711-1711.e8. PubMed ID: 23916083
    [No Abstract]   [Full Text] [Related]  

  • 19. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
    Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual performance using a retinal prosthesis in three subjects with retinitis pigmentosa.
    Yanai D; Weiland JD; Mahadevappa M; Greenberg RJ; Fine I; Humayun MS
    Am J Ophthalmol; 2007 May; 143(5):820-827. PubMed ID: 17362868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.